Comparative Study: Proving Performance Parity of the Gerteis Small-Scale Mill to De-Risk and Accelerate Development
Our Process and Product Development group rigorously tested the HM against the integrated mills of the Gerteis Mini-Polygran® (MPG) and Mini-Pactor® (MP) roller compactors. The study confirmed that Granule Size Distributions (GSDs) were nearly identical across all three mill types when processing both brittle and ductile formulations at various solid fractions and with different mill screen sizes.
This proven performance parity is a significant benefit for Serán's customers. It means we can confidently:
• Use gram-scale quantities of API to generate data that is directly representative of larger-scale processes.
• Accelerate formulation screening and process optimization, saving valuable time and resources.
• De-risk scale-up by establishing a reliable link between early-phase experiments and future manufacturing success.
This capability underscores Serán's commitment to science-driven development, enabling us to help our partners move programs forward more efficiently and with greater confidence.
We hope you'll enjoy reading our most recent study.
Authors:
Vedant G Bhagali a, Hamad Haider a, Randy J Wald a* a SeránBioscience LLC, Process and Product Development, OR 97701, USA , GerteisMaschinen + Processengineering AG
Corresponding Author:
Randy J Wald
Study in collaboration with:
Gerteis Maschinen + Processengineering AG
Michael Schupp, Head of Technology & Process Engineering
Acknowledgement: The authors would like to acknowledgeGregory R. Ellis for his contributions to the initial data collection &characterization.
About Serán
Serán BioScience, LLC, is a science-driven Drug Development Partner, recognized as a world leader in drug development. Utilizing a foundation of physical and chemical science, Serán designs robust formulations and engineered solutions to some of the industry's toughest drug product problems. Our experience and background cover a wide range of pharmaceutical manufacturing concepts bringing our world-class expertise to you and your drug product. Serán’s team has decades of experience developing complex drug molecules into enabling medicines. With every addition to our team, we further our commitment to our clients’ success. From preclinical to GMP and beyond, Serán is here to support you and your drug product every step of the way.
For more information, visit www.Seranbio.com or email us at hello@seranbio.com.
Contact
Serán BioScience, LLC
63047 Layton Ave, Bend, OR 97701 USA
www.seranbio.com
